LifeStance Health Group, Inc. (LFST) Stock Analysis
Range Bound setup
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $7.60, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%).
LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed clinicians in 33 states, treating 1.0M+ unique patients through ~9.0M visits in 2025. Revenue is earned on a per-visit fee-for-service basis, with 90% from commercial... Read more
Hold if already holding. Not a fresh buy at $7.60, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%). Chart setup: RSI 51 mid-range, Bollinger mid-band. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 5.4/10, moderate confidence.
Passes 7/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent Developments — LifeStance Health Group, Inc.
Latest news
- LifeStance to Present at Upcoming Investor Conferences - GlobeNewswire — GlobeNewswire neutral
- A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors. - The Motley Fool — The Motley Fool negative
- Robert Bessler Sells LifeStance Health Shares Valued at $492,000 - HarianBasis.co — HarianBasis.co negative
- A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors. - The Globe and Mail — The Globe and Mail negative
- Why LifeStance Health Group (LFST) Stock Is Up Today - Yahoo Finance — Yahoo Finance positive
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerElevance Health15%10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue, respectively'
- HIGHCustomerUnitedHealthcare14%10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue, respectively'
Material Events(8-K, last 90d)
- 2026-03-11Item 5.02LOWLisa Miller promoted to Chief Operating Officer and Principal Operating Officer effective March 10, 2026. Previously EVP, Practice Operations since February 2024. Internal appointment; no officer departure.SEC filing →
- 2026-02-25Item 5.02LOWKenneth Burdick, Executive Chairman, announced planned transition to non-executive Chairman effective March 16, 2026. Not due to disagreement with management or Board. Will participate in standard non-employee director compensation.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $7.60, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%). Chart setup: RSI 51 mid-range, Bollinger mid-band. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $9.33 (+22.8%), stop $7.25 (−4.8%), A.R:R 1.5:1. Score 5.4/10, moderate confidence.
Take-profit target: $9.33 (+19.6% upside). Target $9.33 (+22.8%), stop $7.25 (−4.8%), A.R:R 1.5:1. Stop-loss: $7.25.
Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1).
LifeStance Health Group, Inc. trades at a P/E of 130.0 (forward 19.7). TrendMatrix value score: 6.0/10. Verdict: Hold.
17 analysts cover LFST with a consensus score of 4.1/5. Average price target: $11.
What does LifeStance Health Group, Inc. do?LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed...
LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed clinicians in 33 states, treating 1.0M+ unique patients through ~9.0M visits in 2025. Revenue is earned on a per-visit fee-for-service basis, with 90% from commercial in-network payors and 5% from government payors.